ReviewAdvanced healthcare materials2025
Integration of Bioengineered Tools in Assisted Reproductive Technologies.
Review in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Recent advances in sex-specific reproductive microphysiological systems for the systematic evaluation of assisted reproductive technology.Materials today. Bio · 2026Review
- Community awareness of assisted reproductive technologies in Jordan: educational gaps and knowledge levels.BMC public health · 2026Article
- Endometrial immune dysregulation shapes CD8Frontiers in immunology · 2026Article
- Integration of Bioengineered Tools in Assisted Reproductive Technologies.Advanced healthcare materials · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infertility affects ≈17.5% of the adult population worldwide, posing significant clinical, emotional, and socioeconomic challenges. Recent advances at the intersection of reproductive medicine and bioengineering offer promising avenues to enhance assisted reproductive technologies (ART). This review synthesizes emerging microengineered and stem cell-based platforms designed to improve key ART stages from gamete handling and fertilization to embryo culture and implantation. State-of-the-art microfluidic systems that refine sperm selection by leveraging directional behavioral responses, enhancing motility, and preserving DNA integrity is discussed. Moreover, devices for oocyte denudation and cryopreservation have been developed to mitigate cellular stress associated with conventional processing techniques. While microengineered platforms demonstrate promise in sperm sorting and reducing stress on gametes, their broader application in ART, particularly for oocyte handling and embryo culture, requires further development. The review further addresses stem cell-based embryo models and bioengineered endometrial platforms, which aim to recapitulate the dynamic in vivo microenvironments needed for successful fertilization, embryo development, and implantation. Despite encouraging preliminary results, challenges such as scalability, reproducibility, clinical validation, and ethical considerations remain. By identifying these gaps and proposing future directions, this review considers integrating microengineering and bioengineering approaches to streamline ART procedures, ultimately enabling more personalized and effective reproductive therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.